A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseases
Abstract After the first reporting of the index case of Severe Acute Respiratory Syndrome (SARS)-CoV-2-associated disease at the end of December 2019, the virus spread quickly throughout the world, prompting the WHO on 11 March 2020 to declare the disease a global pandemic. The coronavirus disease 2...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2023-01-01
|
| Series: | Virology Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12985-023-01967-7 |
| _version_ | 1797958803991298048 |
|---|---|
| author | Zahra Hamidi Shaghaiegh Jabraeili-Siahroud Yalda Taati-Alamdari Parisa Shiri Aghbash Ali Shamekh Hossein Bannazadeh Baghi |
| author_facet | Zahra Hamidi Shaghaiegh Jabraeili-Siahroud Yalda Taati-Alamdari Parisa Shiri Aghbash Ali Shamekh Hossein Bannazadeh Baghi |
| author_sort | Zahra Hamidi |
| collection | DOAJ |
| description | Abstract After the first reporting of the index case of Severe Acute Respiratory Syndrome (SARS)-CoV-2-associated disease at the end of December 2019, the virus spread quickly throughout the world, prompting the WHO on 11 March 2020 to declare the disease a global pandemic. The coronavirus disease 2019 (COVID-19) pandemic, raises concerns for all people, mainly for susceptible population. People with pre-existing diseases, especially individuals with autoimmune disorders, are more at the risk of SARS-CoV-2 infection because of compromised immune system due to frequent use of immunosuppressive drugs and steroids. Patients with autoimmune diseases and their physicians have concerns about these patients’ healthcare, since they are at a higher risk for COVID-19 infection, may show severe complications of COVID-19, and may experience probable flares of their pre-existing disease. Even though there have been several studies discussing the relation between COVID-19 and various types of autoimmune diseases, it cannot be ascertained that all patients with autoimmune diseases experience more severe complications of COVID-19 and have more hospitalization or mortality rate. The situation depends on each patient’s condition, such as the type and the severity of the underlying autoimmune disease and the kind of treatment they receive. In the present review, we have discussed the effects of COVID-19 pandemic on patients with different autoimmune diseases and their relative concerns about their treatments. As a result, we have reviewed further considerations that should be taken into account for these patients during the pandemic or when they are infected with COVID-19. |
| first_indexed | 2024-04-11T00:25:02Z |
| format | Article |
| id | doaj.art-60d4411c2b9441928da65bed3c0ae370 |
| institution | Directory Open Access Journal |
| issn | 1743-422X |
| language | English |
| last_indexed | 2024-04-11T00:25:02Z |
| publishDate | 2023-01-01 |
| publisher | BMC |
| record_format | Article |
| series | Virology Journal |
| spelling | doaj.art-60d4411c2b9441928da65bed3c0ae3702023-01-08T12:04:40ZengBMCVirology Journal1743-422X2023-01-0120111110.1186/s12985-023-01967-7A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseasesZahra Hamidi0Shaghaiegh Jabraeili-Siahroud1Yalda Taati-Alamdari2Parisa Shiri Aghbash3Ali Shamekh4Hossein Bannazadeh Baghi5Student Research Committee, Tabriz University of Medical SciencesStudent Research Committee, Tabriz University of Medical SciencesStudent Research Committee, Tabriz University of Medical SciencesImmunology Research Center, Tabriz University of Medical SciencesStudent Research Committee, Tabriz University of Medical SciencesImmunology Research Center, Tabriz University of Medical SciencesAbstract After the first reporting of the index case of Severe Acute Respiratory Syndrome (SARS)-CoV-2-associated disease at the end of December 2019, the virus spread quickly throughout the world, prompting the WHO on 11 March 2020 to declare the disease a global pandemic. The coronavirus disease 2019 (COVID-19) pandemic, raises concerns for all people, mainly for susceptible population. People with pre-existing diseases, especially individuals with autoimmune disorders, are more at the risk of SARS-CoV-2 infection because of compromised immune system due to frequent use of immunosuppressive drugs and steroids. Patients with autoimmune diseases and their physicians have concerns about these patients’ healthcare, since they are at a higher risk for COVID-19 infection, may show severe complications of COVID-19, and may experience probable flares of their pre-existing disease. Even though there have been several studies discussing the relation between COVID-19 and various types of autoimmune diseases, it cannot be ascertained that all patients with autoimmune diseases experience more severe complications of COVID-19 and have more hospitalization or mortality rate. The situation depends on each patient’s condition, such as the type and the severity of the underlying autoimmune disease and the kind of treatment they receive. In the present review, we have discussed the effects of COVID-19 pandemic on patients with different autoimmune diseases and their relative concerns about their treatments. As a result, we have reviewed further considerations that should be taken into account for these patients during the pandemic or when they are infected with COVID-19.https://doi.org/10.1186/s12985-023-01967-7Autoimmune diseasesCOVID-19Immune systemSARS-CoV-2 |
| spellingShingle | Zahra Hamidi Shaghaiegh Jabraeili-Siahroud Yalda Taati-Alamdari Parisa Shiri Aghbash Ali Shamekh Hossein Bannazadeh Baghi A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseases Virology Journal Autoimmune diseases COVID-19 Immune system SARS-CoV-2 |
| title | A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseases |
| title_full | A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseases |
| title_fullStr | A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseases |
| title_full_unstemmed | A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseases |
| title_short | A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseases |
| title_sort | comprehensive review of covid 19 symptoms and treatments in the setting of autoimmune diseases |
| topic | Autoimmune diseases COVID-19 Immune system SARS-CoV-2 |
| url | https://doi.org/10.1186/s12985-023-01967-7 |
| work_keys_str_mv | AT zahrahamidi acomprehensivereviewofcovid19symptomsandtreatmentsinthesettingofautoimmunediseases AT shaghaieghjabraeilisiahroud acomprehensivereviewofcovid19symptomsandtreatmentsinthesettingofautoimmunediseases AT yaldataatialamdari acomprehensivereviewofcovid19symptomsandtreatmentsinthesettingofautoimmunediseases AT parisashiriaghbash acomprehensivereviewofcovid19symptomsandtreatmentsinthesettingofautoimmunediseases AT alishamekh acomprehensivereviewofcovid19symptomsandtreatmentsinthesettingofautoimmunediseases AT hosseinbannazadehbaghi acomprehensivereviewofcovid19symptomsandtreatmentsinthesettingofautoimmunediseases AT zahrahamidi comprehensivereviewofcovid19symptomsandtreatmentsinthesettingofautoimmunediseases AT shaghaieghjabraeilisiahroud comprehensivereviewofcovid19symptomsandtreatmentsinthesettingofautoimmunediseases AT yaldataatialamdari comprehensivereviewofcovid19symptomsandtreatmentsinthesettingofautoimmunediseases AT parisashiriaghbash comprehensivereviewofcovid19symptomsandtreatmentsinthesettingofautoimmunediseases AT alishamekh comprehensivereviewofcovid19symptomsandtreatmentsinthesettingofautoimmunediseases AT hosseinbannazadehbaghi comprehensivereviewofcovid19symptomsandtreatmentsinthesettingofautoimmunediseases |